• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用西多福韦成功治疗对干扰素和异维甲酸耐药的复发性外阴上皮内瘤变。

Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.

作者信息

Koonsaeng S, Verschraegen C, Freedman R, Bossens M, Kudelka A, Kavanagh J, Sittisomwong T, DeClercq E, Snoeck R

机构信息

Gynecologic Oncology Unit, National Cancer Institute, Bangkok, Thailand.

出版信息

J Med Virol. 2001 Jun;64(2):195-8. doi: 10.1002/jmv.1036.

DOI:10.1002/jmv.1036
PMID:11360253
Abstract

Vulvar intraepithelial neoplasias are difficult to eradicate completely without extensive surgical intervention. Cidofovir, a deoxycytidine monophosphate analog, may have a therapeutic role in this disease. A 43-year-old woman with a 20-year history of genital warts presented with extensive vulvar intraepithelial neoplasia III, and refused surgical resection. Topical cidofovir 1% in Beeler base completely eradicated the lesion. Successive treatment applications, however, were necessary. Cidofovir is a promising topical antiviral compound for HPV induced vulvar intraepithelial neoplasia.

摘要

外阴上皮内瘤变若不进行广泛的手术干预,很难完全根除。西多福韦是一种单磷酸脱氧胞苷类似物,可能对这种疾病具有治疗作用。一名有20年尖锐湿疣病史的43岁女性,患有广泛的外阴上皮内瘤变III级,拒绝手术切除。在Beeler基质中使用1%的西多福韦局部用药完全消除了病变。然而,需要连续进行治疗。西多福韦是一种有前景的用于治疗人乳头瘤病毒引起的外阴上皮内瘤变的局部抗病毒化合物。

相似文献

1
Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.用西多福韦成功治疗对干扰素和异维甲酸耐药的复发性外阴上皮内瘤变。
J Med Virol. 2001 Jun;64(2):195-8. doi: 10.1002/jmv.1036.
2
Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia.西多福韦局部应用于高级别外阴上皮内瘤变女性患者的临床反应。
Gynecol Oncol. 2005 Dec;99(3):652-5. doi: 10.1016/j.ygyno.2005.07.127. Epub 2005 Sep 16.
3
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.西多福韦和咪喹莫特治疗外阴上皮内瘤变(RT³VIN)的活性、安全性和可行性:一项多中心、开放性标签、随机、2 期试验。
Lancet Oncol. 2014 Nov;15(12):1361-8. doi: 10.1016/S1470-2045(14)70456-5. Epub 2014 Oct 7.
4
Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.局部用西多福韦治疗皮肤病:疣、尖锐湿疣、上皮内瘤变、单纯疱疹及其在天花中的潜在应用。
Dermatol Clin. 2003 Apr;21(2):301-9. doi: 10.1016/s0733-8635(02)00116-x.
5
Topical cidofovir for bowenoid papulosis in an HIV-infected patient.
Br J Dermatol. 2001 Mar;144(3):642-3. doi: 10.1046/j.1365-2133.2001.04112.x.
6
Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.局部应用西多福韦治疗 HIV 阳性男性和女性肛周及外阴高级别上皮内瘤变的安全性和有效性。
AIDS. 2013 Feb 20;27(4):545-51. doi: 10.1097/QAD.0b013e32835a9b16.
7
Surgery or topical therapy for vulval intraepithelial neoplasia.外阴上皮内瘤变的手术或局部治疗。
Lancet Oncol. 2014 Nov;15(12):1287-8. doi: 10.1016/S1470-2045(14)70491-7. Epub 2014 Oct 7.
8
Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).西多福韦,一种治疗宫颈上皮内瘤变III级(CIN III)的新方法。
J Med Virol. 2000 Feb;60(2):205-9. doi: 10.1002/(sici)1096-9071(200002)60:2<205::aid-jmv16>3.0.co;2-8.
9
Topical 1% cidofovir for the treatment of vulvar intraepidermal neoplasia (VIN1) developed on lichen sclerosus.
Int J Dermatol. 2009 May;48(5):535-6. doi: 10.1111/j.1365-4632.2009.04003.x.
10
Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata.局部用西多福韦(HPMPC)是治疗尖锐湿疣手术治疗的一种有效辅助手段。
Dis Colon Rectum. 2003 Aug;46(8):1103-8; discussion 1108-9. doi: 10.1007/s10350-004-7287-5.

引用本文的文献

1
HPV Carcinomas in Immunocompromised Patients.免疫功能低下患者的人乳头瘤病毒相关癌
J Clin Med. 2015 Jan 29;4(2):260-81. doi: 10.3390/jcm4020260.
2
Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovir.对西法韦选择耐药的宫颈癌 SiHa 细胞的致瘤性和致病性降低。
Mol Cancer. 2013 Dec 10;12:158. doi: 10.1186/1476-4598-12-158.
3
Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage.西多福韦的选择性基于正常细胞和癌细胞对 DNA 损伤的不同反应。
BMC Med Genomics. 2013 May 23;6:18. doi: 10.1186/1755-8794-6-18.
4
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.无环核苷膦酸酯西多福韦、阿德福韦和替诺福韦在治疗DNA病毒和逆转录病毒感染方面的临床潜力。
Clin Microbiol Rev. 2003 Oct;16(4):569-96. doi: 10.1128/CMR.16.4.569-596.2003.